Forecast & Rating4 analysts currently cover Runben Biotechnology, of which 4 give a positive rating. The average price target is ¥31.18, about 49.9% upside from the current price of ¥20.80. Coverage is limited, so the data is for reference only. Data as of Aug 25, 2026; this does not constitute investment advice.
Aug 25, 2026Price forecast
¥31.1849.90%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met49.7%
Stock price$20.80
Avg. target$34.5
High target$36
Low target$33
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.